Peloid Therapy in Temporomandibular Joint Dysfunction
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUşak University
About this trial
This prospective, single-group clinical study will evaluate whether local peloid therapy improves pain and jaw function in adults with temporomandibular joint dysfunction. Participants will receive peloid therapy applied to the temporomandibular joint region and masticatory muscles for 20 minutes per session, 5 days per week, for 2 weeks. Pain and functional outcomes will be measured at baseline and at the end of treatment using validated clinical scales, including the Jaw Functional Limitation Scale-8, visual analog scale pain scores, Fonseca index, maximum mouth opening, and secondary otalgia assessment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 18 and 65 years
Diagnosis of temporomandibular joint dysfunction based on DC/TMD criteria
Presence of TMJ-related pain for at least 4 weeks
Baseline pain intensity ≥3 on a 0-10 visual analog scale
Disqualifiers
History of temporomandibular joint trauma, tumor, active infection, or acute inflammation
Previous temporomandibular joint surgery
Presence of systemic inflammatory rheumatologic disease
Pregnancy
Trial design
Design model
Single group
Treatments tested in this trial
Local Peloid Therapy
Other interventionParticipants will receive local peloid therapy applied externally over the temporomandibular joint region and adjacent masticatory muscles. The treatment will be delivered as 10 sessions over 2 weeks, with 5 sessions per week. Each session will last 20 minutes. Peloid therapy will be administered by a trained investigator according to the study protocol.
Treatment groups
40 Participants
are divided into 1 treatment groupGroup A: Peloid TherapyExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in Jaw Function Score at Week 2
Jaw function will be assessed using the Jaw Functional Limitation Scale-8 (JFLS-8). This is a patient-reported questionnaire that measures limitation in jaw activities such as chewing, speaking, and mouth opening. The total score ranges from 0 to 10, where 0 indicates no functional limitation and 10 indicates the highest level of limitation. The primary outcome will be the change in JFLS-8 total score from baseline to Week 2.
Time frame
Baseline and Week 2Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov